20 January 2023 - The TGA has commenced evaluation of an application from Moderna to transition its COVID-19 vaccine, Spikevax, to full registration for the immunisation of individuals 6 years and over, and as a booster dose for individuals aged 12 years and older.
This is the first application received by the TGA to transition a provisionally approved COVID-19 vaccine to full registration.